CIDRAP newsletters options
The Vaccine Integrity Project staff and advisors note the conspicuous and consequential absence of US health agency vaccine campaigns and annual vaccination reminders ahead of respiratory virus season.
Supported vaccines saved a record 1.7 million lives, 400,000 more than in 2023, and made headway in conflict countries.
FDA officials say they have determined Dectomax-CA1 is safe and has a reasonable expectation of effectiveness against the flesh-eating parasitic infection.
The US State Department announced it will introduce the HIV-prevention drug lenacapavir in Uganda through PEPFAR.
The white-tailed doe was reported in July after showing clinical signs of the fatal neurodegenerative disease.
Data on the efficacy of RSV vaccines on women of childbearing age and on infants and children were more limited.
In-hospital death among nebulized-heparin recipients was 4%, compared with 14% in controls.
In other developments, Canadian officials announce that the D1.3 genotype was identified in recent samples from ostriches at the center of a firestorm over culling.
Elsewhere, Israel has now reported 6 child deaths from measles, 4 of them over the past week.
Twenty people in 15 states have been now sickened in the outbreak, and 4 have died.
81% correctly said the best defense against the virus was avoiding getting bitten by a mosquito.
The reports provide more detail on the deadliest flu season for US children in more than a decade.
Samples available for one of the cats revealed the B3.13 genotype, and genetic sequencing at the USDA lab is underway.
Changes in, or loss of, sense of smell can have a profound impact on a person's well-being, the authors say.
In other developments, the CDC reported one more pediatric flu death, raising the season's total to 281, the highest for a nonpandemic year.
The two influenza A picks are different from the current Northern Hemisphere vaccines and from last season's Southern Hemisphere vaccines.
Among those not treated, 2,535 had RSV-associated admissions, compared with 850 in the treated group.
The vaccine campaign targeting almost 2 million people in Darfur region faces daunting access and transportation challenges amid ongoing conflict.
One found 44% better protection for the high-dose version against hospitalization for flu but not for flu or pneumonia, which goes against previous findings.
Approval for the HHS secretary has dropped from a June 11 poll.
